TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.

BMC Cancer · 2005 · PMC1276789 · PMID 16229746

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp = 0.06so close (0.05 < p ≤ 0.1)

Notably, interaction between BRCA1 status and TP53 status was borderline significant (test for interaction: p = 0.06) while the one between BRCA1 status and age at diagnosis was statistically significant (test for interaction: p = 0.05).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.